PRESS
Press Coverage of Research
Dr. Juan Hincapie-Castillo advocates for empathy and safety in pharmaceutical policies. The Pivot - UNC Gillings School of Global Public Health (05/31/2022)
NSAID Prescriptions Remain Flat After Enactment of Florida Opioid Restriction Law. Pain Medicine News (08/20/2021)
Quinolones FDA Label Changes Resulted in Prescribing Decline. Medscape (04/22/2021)
High Costs Lead Millions of Americans to Shop Abroad for Rx Drugs. US News & World Report (06/26/2020)
Changes in Opioid Use after Florida’s Restriction Law Linked to Fewer New Users. Pain Medicine News (05/18/2020)
Florida Law Tightened Opioid Prescribing, and Saw Usage Drop. US News & World Report. (03/03/2020)
Florida law limiting first opioid prescription linked to drop in use. Reuters. (02/28/2020)
The New York Times (02/28/2020), Yahoo! News (02/28/2020), Medscape (03/03/2020)
Commentary in Media
World Health Organization rebrands 'monkeypox' as mpox. Does it matter? Salon (12/06/2022)
Undergraduate Pain Course Welcomes Anyone ‘With a Curiosity About Pain. Pain Medicine News (011/22/2021)
Outpatient Buprenorphine Dispensing in Texas Increased in Early Months of Pandemic. Pain Medicine News (05/11/2021)
"The Huge Problem of Health Policies with Juan M Hincapie Castillo." 21st Century Pain Solutions Podcast. Episode 81 (06/2020)
Pharmacists Use Running to Improve their Mental and Physical Health. ASHP Intersections. (1/27/2020)
Op-Ed
Prior Authorization Insurance Requirements: A Barrier to Accessing Lifesaving Treatment for Opioid Use Disorder? Bill of Health. Petrie-Flom Center Harvard Law. August 22, 2022
Opioid prescription limits have unintended consequences. Gainesville Sun, The (FL). March 2, 2020
Short Bio
Juan M. Hincapie-Castillo is an assistant professor at the Department of Epidemiology at the University of North Carolina at Chapel Hill. He is a graduate from the University of Florida College of Pharmacy where he received the degrees of Doctor of Pharmacy (2013), Master of Science in Pharmaceutical Sciences (2017), and Ph.D. with a concentration in pharmacoepidemiology (2019). He is the recipient of the 2020 New Investigator Award from the American Association of Colleges of Pharmacy and the 2020 Emerging Leader Award from the International Society for Pharmacoepidemiology (ISPE). His research interests include the study of drug utilization and safety in the area of pain management, the evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and the assessment of patient safety and quality for inpatient pain management.
Juan is a consultant for the FDA’s Drug Safety and Risk Management Advisory Committee (DSaRM). In 2021, he was appointed as a Research Fellow for the Center for Public Health Law Research (CPHLR) at Temple University. He currently serves President of the Board of Directors for the National Pain Advocacy Center (NPAC).
